Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

Delayed Data
As of 11:46am ET
 -3.33 / -3.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 54.00, with a high estimate of 59.00 and a low estimate of 46.00. The median estimate represents a -35.23% decrease from the last price of 83.37.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -191.94%
Growthannually 3.02%


Growthquarterly -46.34%
Growthannually 36.78%
Key to the earnings and sales forecast charts.